Event Specialty: Bronchoscopy
CHEST 2018 October 6-10, 2018 Auris Health will be showcasing the Monarch Platform, the only FDA-cleared robotic bronchoscopy.
Please join Kyle Hogarth, M.D. from University of Chicago Medicine to learn more about robotic bronchoscopy. Location: CHEST Conference, Auris Booth #1236 Tuesday, October 9th 11:00-11:30 am
Associate Professor of Medicine Director, Bronchoscopy Co-Director, Lung Cancer Screening Program Medical Director, Pulmonary Rehabilitation Program President, Society for Advanced Bronchoscopy
Live demonstrations of the Monarch Platform's driving into the periphery towards small nodules will feature - a novel user interface using a controller to drive the robotic arms - an integrated display combining bronchoscopic views, virtual navigation views and CT slices - precise and controlled micromovements that only a robotic arm can perform
Auris Health will be exhibiting at CHEST 2018 at booth #1236 two aisles to the left of Learning Theatre 1.
Please join Alexander C. Chen, M.D. from Washington University School of Medicine to learn more about robotic bronchoscopy.
Location: CHEST Conference, Room 216B Monday, October 8th 5:15-5:30pm
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.